Global Peripheral Vascular Intervention Device Market Growth (Status and Outlook) 2026-2032
Description
The global Peripheral Vascular Intervention Device market size is predicted to grow from US$ 10932 million in 2025 to US$ 18061 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.
Peripheral Vascular Interventional Devices are minimally invasive medical devices used for the diagnosis and treatment of non-coronary vascular diseases, including peripheral arteries, veins, and related vascular access pathways. These devices mainly include balloon catheters, vascular stents, guidewires, catheters, thrombectomy systems, and drug-coated products. Under imaging guidance such as DSA, CT, or ultrasound, they are delivered percutaneously to target lesions to dilate, support, or restore blood flow in stenotic or occluded vessels. Their technological core lies in the integration of advanced materials, structural design, and delivery systems to ensure optimal trackability, flexibility, and long-term efficacy. With advantages such as minimal invasiveness, rapid recovery, and repeatability, these devices are widely applied in peripheral artery disease, venous thrombosis, and tumor interventions, representing a key shift toward precision and minimally invasive vascular therapies.The average gross profit margin of this product is 73%.
The growing prevalence of peripheral vascular diseases, driven by aging populations and increasing metabolic disorders, is significantly boosting clinical demand for interventional therapies. The shift toward minimally invasive treatment models has strengthened the role of interventional procedures in vascular care pathways. Meanwhile, advancements in drug-coated technologies, bioresorbable materials, and imaging guidance systems have improved clinical outcomes and expanded indications. In emerging markets, improving healthcare infrastructure and rising affordability are providing sustained growth opportunities.The industry is characterized by high technical barriers, requiring strong capabilities in material science, precision manufacturing, and clinical validation, along with long development cycles and high investment. The global high-end segment remains dominated by multinational companies, while local players face challenges in branding and channel development. Policy factors such as centralized procurement and healthcare cost controls exert downward pressure on pricing and margins. Additionally, procedural success is highly dependent on physician expertise, and complex lesions still carry treatment risks, affecting adoption rates.Clinical demand is increasingly focused on device performance, particularly in terms of deliverability, radial strength, and long-term patency. Treatment settings are gradually extending from large hospitals to primary care institutions, driving demand for user-friendly and standardized products. With the rise of day surgery and enhanced recovery concepts, minimally invasive and short-duration procedures are gaining preference. At the same time, growing demand in venous diseases and tumor interventions is accelerating product segmentation and technological upgrades.Upstream components mainly include medical-grade polymers, metallic materials, and functional coating materials, with nitinol, stainless steel, and high-performance polymers being key materials. These materials directly determine flexibility, support performance, and biocompatibility, playing a critical role in device functionality. Currently, some high-end raw materials still rely on imports, making supply chain stability and cost control important concerns. With advancements in domestic material technologies, localization is accelerating, although higher requirements for quality consistency and process control are emerging.
LPI (LP Information)' newest research report, the “Peripheral Vascular Intervention Device Industry Forecast” looks at past sales and reviews total world Peripheral Vascular Intervention Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Peripheral Vascular Intervention Device sales for 2026 through 2032. With Peripheral Vascular Intervention Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Vascular Intervention Device industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Vascular Intervention Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peripheral Vascular Intervention Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral Vascular Intervention Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Vascular Intervention Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Vascular Intervention Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Vascular Intervention Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Segmentation by Material:
Arterial Diseases
Venous Diseases
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Zylox-Tonbridge Medical
Endovastec
ACOTEC
LifeTech Scientific
WEGO
Brosmed
DK MEDTECH
Barty Medical
Please note: The report will take approximately 2 business days to prepare and deliver.
Peripheral Vascular Interventional Devices are minimally invasive medical devices used for the diagnosis and treatment of non-coronary vascular diseases, including peripheral arteries, veins, and related vascular access pathways. These devices mainly include balloon catheters, vascular stents, guidewires, catheters, thrombectomy systems, and drug-coated products. Under imaging guidance such as DSA, CT, or ultrasound, they are delivered percutaneously to target lesions to dilate, support, or restore blood flow in stenotic or occluded vessels. Their technological core lies in the integration of advanced materials, structural design, and delivery systems to ensure optimal trackability, flexibility, and long-term efficacy. With advantages such as minimal invasiveness, rapid recovery, and repeatability, these devices are widely applied in peripheral artery disease, venous thrombosis, and tumor interventions, representing a key shift toward precision and minimally invasive vascular therapies.The average gross profit margin of this product is 73%.
The growing prevalence of peripheral vascular diseases, driven by aging populations and increasing metabolic disorders, is significantly boosting clinical demand for interventional therapies. The shift toward minimally invasive treatment models has strengthened the role of interventional procedures in vascular care pathways. Meanwhile, advancements in drug-coated technologies, bioresorbable materials, and imaging guidance systems have improved clinical outcomes and expanded indications. In emerging markets, improving healthcare infrastructure and rising affordability are providing sustained growth opportunities.The industry is characterized by high technical barriers, requiring strong capabilities in material science, precision manufacturing, and clinical validation, along with long development cycles and high investment. The global high-end segment remains dominated by multinational companies, while local players face challenges in branding and channel development. Policy factors such as centralized procurement and healthcare cost controls exert downward pressure on pricing and margins. Additionally, procedural success is highly dependent on physician expertise, and complex lesions still carry treatment risks, affecting adoption rates.Clinical demand is increasingly focused on device performance, particularly in terms of deliverability, radial strength, and long-term patency. Treatment settings are gradually extending from large hospitals to primary care institutions, driving demand for user-friendly and standardized products. With the rise of day surgery and enhanced recovery concepts, minimally invasive and short-duration procedures are gaining preference. At the same time, growing demand in venous diseases and tumor interventions is accelerating product segmentation and technological upgrades.Upstream components mainly include medical-grade polymers, metallic materials, and functional coating materials, with nitinol, stainless steel, and high-performance polymers being key materials. These materials directly determine flexibility, support performance, and biocompatibility, playing a critical role in device functionality. Currently, some high-end raw materials still rely on imports, making supply chain stability and cost control important concerns. With advancements in domestic material technologies, localization is accelerating, although higher requirements for quality consistency and process control are emerging.
LPI (LP Information)' newest research report, the “Peripheral Vascular Intervention Device Industry Forecast” looks at past sales and reviews total world Peripheral Vascular Intervention Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Peripheral Vascular Intervention Device sales for 2026 through 2032. With Peripheral Vascular Intervention Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Vascular Intervention Device industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Vascular Intervention Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peripheral Vascular Intervention Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral Vascular Intervention Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Vascular Intervention Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Vascular Intervention Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Vascular Intervention Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Segmentation by Material:
Arterial Diseases
Venous Diseases
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Zylox-Tonbridge Medical
Endovastec
ACOTEC
LifeTech Scientific
WEGO
Brosmed
DK MEDTECH
Barty Medical
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
132 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Peripheral Vascular Intervention Device Market Size by Player
- 4 Peripheral Vascular Intervention Device by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Peripheral Vascular Intervention Device Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
